Background {#S0001}
==========

Kawasaki disease (KD) is an acute, self-limited vasculitis of unknown etiology that occurs predominantly in infants and young children.[@CIT0001] It is characterized by fever, bilateral nonexudative conjunctivitis, erythema of the lips and oral mucosa, extremity changes, rash, and cervical lymphadenopathy. The systemic vasculitis mainly affects medium-sized arteries in multiple systems, especially the coronary arteries. Administration of high-dose intravenous immunoglobulin reduces the incidence of coronary artery lesions (CALs) from 20% to 25% to \<5% in the acute phase.[@CIT0001]

As a systemic vasculitis, KD damages not only the medium-sized arteries but also the small arteries and veins.[@CIT0002] Although KD is self-limited, there are pathological changes in the convalescent period, including infiltration of the vascular wall by macrophages, lymphocytes (primarily CD8+ T cells), and plasma cells,[@CIT0003] whichcan cause artery wall remodeling. These changes may cause systemic artery stiffness and damage vascular function in the late phase of KD and thus infer a higher risk of cardiovascular disease. Some studies have reported that KD can cause both structural and functional systemic abnormalities that persist long after the acute phase.[@CIT0004]--[@CIT0007] Other studies have verified the association between KD and atherosclerosis.[@CIT0008]--[@CIT0012]

We recently reported that children and adolescents with a history of KD have slight but significant elastic arterial stiffness despite having no CALs.[@CIT0013] We hypothesized that KD-related arteriopathy also affected peripheral artery function other than central artery function. As a parameter associated with wave reflection and the stiffness of resistance vessels, the radial artery augmentation index (rAI) can reflect systemic artery stiffness,especially in the peripheral sites. Our study collected the rAI data in both patients with KD and healthy controls in order to investigate possible differences between the two groups.

Materials and methods {#S0002}
=====================

Study subjects {#S0002-S2001}
--------------

We conducted the study from May 2013 to April 2016 in the pediatric department of a hospital affiliated with the Kanazawa Medical University. Consecutive pediatric patients older than 4 years with a diagnosis of KD for \>1 month were recruited. We used the Japanese criteria (the fifth revised edition in 2002) for the diagnosis of KD. All patients were given standard treatment, including intravenous immunoglobulin and high doses of aspirin (30--50 mg/kg). Unaffected subjects mainly in the same age range without a history of KD were assigned as control group. Some of them were the children whose parents worked in our hospital and the others were the ones who took a health check in our department. All subjects in both groups were Japanese nonsmokers without a medical history of hypertension, hyperglycemia,or hypercholesterolemia. None had a known family history of hereditary disease. This study was approved by the ethics committee of Kanazawa Medical University (the approval number: NO.R213), and written informed consent for participation was obtained from all subjects or from their parents.

Study protocol {#S0002-S2002}
--------------

We reviewed the medical history of all participants and measured their body weight (BW), height (HT), heart rate (HR), and blood pressure (BP). Body mass index (BMI) was calculated using the formula BW/H^2^. The acute-phase clinical data of patients with KD were reviewed carefully to collect the following details: age at disease onset, time interval between disease onset and the date of the examination for the study, and whether CALs were present or not. We used the Japanese criteria (fifth revised edition) to identify CALs, which were considered present if any of the following criteria were met: 1) the internal lumen diameter was \>3 mm in children under 5 years or \>4 mm in children 5 years or older; 2) the internal diameter of any segment was at least 1.5-fold larger than that of an adjacent segment; or 3) the coronary artery lumen was conspicuously irregular. Subjects with CALs during the acute phase were excluded from our study. rAI measurement is described below.

rAI measurements {#S0002-S2003}
----------------

The Omron HEM-9000AI (Omron Healthcare Co., Ltd, Japan) was used to measure the rAI. Participants were advised not to consume food or drink except for water for at least 3 hrs before the rAI examination. After resting for at least 15 mins in a quiet examination room, each subject was examined in a sitting position by experienced doctors. Due to the necessary cooperation problem, we only included children who were over 4 years old. For the younger children, in addition to the operator, a nurse and the caregiver (mother) were present in the room throughout the assessment. The nurse played an age-appropriate video to the child before and during the procedure. The assessment did not start until the child was comfortable and the questions of the child and caregiver were answered. After the preparation, the pulse wave sensor unit was placed over the radial artery pulse spot and fixed. The radial artery waveform ([Figure 1](#F0001){ref-type="fig"}) was recorded, and the rAI was calculated using the formula rAI = (P2/P1\*100), where systolic peak pressure 2 (P2) is the late systolic pressure and systolic peak pressure 1 (P1) is the early systolic pressure. As the rAI may be influenced by heart rate, it was adjusted to 75 bpm (rAI\@75) for heart rate standardization.Figure 1Radial artery waveform.**Abbreviations:**rAI, radial artery augmentation index; P2, systolic peak pressure 2; P1, systolic peak pressure 1.

Data including procedure {#S0002-S2004}
------------------------

Primarily, 312 subjects were recruited. The children younger than 6 years old were excluded because of the cooperation problem during the AI measurement even after full preparation. According to Tomoaki Murakami's[@CIT0014] and EV Hidvégi's study,[@CIT0015] the linear decreasing trend of AI changed around 15 years old; we thus have not included the cases over 15 years old for more accurate data analysis. Moreover, 5 cases reached the criteria of hypertention[@CIT0016] and 25 cases had an abnormal BMI index (≥2SD) according to WHO child growth standards 2006; they were also excluded. Finally, 225 cases were included and 41 pairs were matched by the same height and gender considering these two factors in determing AI value in healthy children.[@CIT0014],[@CIT0015] The whole procedure was summarized in [Figure 2](#F0002){ref-type="fig"}Figure 2Data including procedure.

Statistical analysis {#S0002-S2005}
--------------------

Continuous data were expressed as mean± SD and nonparametric statistical analysis was used. Categorical data were analyzed using the Chi-square test. We performed multivariable regression analysis using the rAI\@75 as the dependent variable. Paired-samples *T* test was employed for paired data analysis. Statistical analyses were performed using the SPSS statistical software package, version 16.0. Missing values were excluded from the analysis. A two-sided *p*-value \<0.05 was considered to indicate statistical significance.

Results {#S0003}
=======

Clinical characteristics {#S0003-S2001}
------------------------

The characteristics of the 225 subjects (123 healthy controls and 102 KD subjects) are listed in [Table 1](#T0001){ref-type="table"}. There was no significant difference in the proportion of boys and girls between KD group and control group (*p*=0.539). The KD group was a little younger than the control group, but this difference was not statistically significant. The KD group had significantly lower values in terms of height and BW (*p*\<0.01). With regard to BP, the diastolic pressure is a little higher in the KD group than the control group (*p*=0.048), whereas no difference existed in systolic pressure and pulse pressure. Although the rAI and rAI\@75 of KD group were significantly higher than the healthy control group, further analysis was needed due to the difference in height and other factors between these two groups.Table 1Subject characteristicsControl (mean ± SD)KD (mean ± SD)*p-*valueAge (years)11.22±2.7310.54±2.660.060\*Height (cm)145.27±17.42138.72±17.190.005\*Male proportion (%)71/123 (57.7%)63/102 (61.8%)0.539^†^Body weight (kg)38.14±11.8333.69±11.450.009\*Systolic pressure (mmHg)103.12±8.18103.11±8.890.884\*Diastolic pressure (mmHg)60.60±8.4762.63±6.490.048\*Pulse pressure (mmHg)42.52±7.6340.48±7.920.059\*rAI56.63±14.4462.51±14.410.003\*rAI\@7557.60±16.1566.00±15.92\<0.001\*[^1][^2]

KD history was positively correlated with rAI and rAI\@75 {#S0003-S2002}
---------------------------------------------------------

Because of the significant difference in height and other factors between KD and healthy controls, univariable analysis to compare the rAI between KD and healthy control group makes little sense. We conducted multivariable regression analysis to reveal the correlation between KD history and rAI. [Tables 2](#T0002){ref-type="table"} and [3](#T0003){ref-type="table"} show height was strongly correlated with rAI and rAI\@75. The elevated height always links with decreased rAI and rAI\@75. The same negative correlation was also found between male sex and rAI\@75, with females having a higher rAI than males. In contrast, KD history was positively correlated with rAI and rAI\@75. In other words, the subjects with KD history had higher rAI\@75 than healthy controls. Due to the strong correlation between height and rAI, we adopted these two variables to draw a scatter plot to better illustrate the relationship between KD history and rAI. [Figures 3](#F0003){ref-type="fig"} and [4](#F0004){ref-type="fig"} also indicate the positive correlation between KD history and rAI and rAI\@75.Table 2Multivariable linear regression analysis for rAIStandard coefficient*p*-valueAge (per year)0.0090.945Body weight (per kg)0.1560.382Sex (male vs female)−0.0880.093Height (per cm)−0.763\<0.001**\*\*\***KD history (KD vs control)0.0920.086[^3][^4] Table 3Multivariable linear regression analysis for rAI\@75Standard coefficient*p*-valueAge (per year)−0.1180.305Body weight (per kg)0.0720.635Sex (male vs female)−0.1150.010**\***Height (per cm)−0.664\<0.001**\*\*\***KD history (KD vs control)0.1330.004**\*\***[^5][^6] Figure 3Linear correlation between rAI and height. Figure 4Linear correlation between rAI\@75 and height.**Abbreviations:** KD, Kawasaki disease; rAI, radial artery augmentation index; rAI\@75, radial artery augmentation index adjusted to heart rate in 75 bpm.

Elevated rAI and rAI\@75 in the KD group after matching height and gender {#S0003-S2003}
-------------------------------------------------------------------------

According to our results of multivariable analysis and linear correlation of scatter plot, height had a strong negative correlation with rAI and rAI\@75; female sex also correlated with elevated rAI and rAI\@75. We paired the KD subjects and healthy controls by matching height and sex (ratio 1:1). 41 pairs were finally included with the same height and sex in each pair. [Table 4](#T0004){ref-type="table"} shows that there was also no significant difference between KD group and healthy controls in terms of age, body surface area (BSA), and BMI. Paired-Samples *t*-test shows that KD group had significantly higher rAI and rAI\@75 than the control group (rAI 60.63±13.77 vs 54.56±13.17, *p*=0.028; r AI\@75 63.61±15.21 vs 55.68±14.86, *p*=0.003). This difference is illustrated in [Figure 5](#F0005){ref-type="fig"}. With regard to heart rate, systolic pressure, and diastolic pressure, no significant difference was found between these two groups.Table 4Paired *t*-test after matching height and sex (1:1)Control (mean ± SD)KD (mean ± SD)*p*-valueAge (years)10.86±2.7311.25±2.590.151BSA (m^2^)1.20±0.251.19±0.240.352BMI (kg/m^2^)17.14±2.0817.09±1.990.861Heart rate (bpm)77.80±13.1481.37±13.630.116Systolic pressure (mmHg)101.54±6.82103.63±8.050.103Diastolic pressure (mmHg)59.78±7.0362.15±5.980.059Pulse pressure (mmHg)41.76±7.7241.49±8.230.847rAI54.56±13.1760.63±13.770.028**\***rAI\@7555.68±14.8663.61±15.210.003**\*\***[^7][^8] Figure 5Comparison of rAI and rAI\@75 after matching HT and sex.**Abbreviations:** rAI, radial artery augmentation index; rAI\@75, radial artery augmentation index adjusted to heart rate in 75 bpm.

Initial intravenous immunoglobulin (IVIG) nonresponse was positively correlated with rAI, whereas fever duration had negative correlation {#S0003-S2004}
-----------------------------------------------------------------------------------------------------------------------------------------

In order to reveal the relationship between acute-phase condition and convalescent rAI, we also performed multivariable linear regression analysis. [Table 5](#T0005){ref-type="table"} shows that initial IVIG nonresponse was positively correlated with rAI. In contrast, fever duration was negatively correlated with rAI and rAI\@75. These results mean that the history of nonresponse to initial IVIG in acute phase would further increase rAI in KD patients, whereas longer fever duration has the opposite effect. But after excluding the cases (n=9) whose fever duration was \<5days, no correlation was found between fever duration and rAI (β=−0.081, *p*=0.419) anymore. With respect to white blood cell (WBC) and C-reactive protein (CRP) in acute phase, we found no correlation with rAI or rAI\@75 in the convalescent period.Table 5Multivariable regression analysis for rAI and rAI\@75 in KD subjectsMean±SDRangeβ\
(rAI)*p*-value\
(rAI)β\
(rAI\@75)*p*-value\
(rAI\@75)Height (cm)138.72±17.19104--176−0.542\<0.001−0.641\<0.001Sex (male proportion)63/10261.76%−0.1980.027**\*\***−0.2030.011**\*\***White blood cell (10^9^/L)13.64±5.364.92--35.42−0.0690.484−0.040.65C-reactive protein (mg/L)7.36±6.020.3--27.64−0.0110.919−0.0080.936Intravenous immunoglobulin (nonresponder proportion)21/10220.5%0.1810.085**\***0.1120.232Fever duration (days)6.55±1.823--10−0.1980.056**\***−0.20.031**\*\***[^9][^10]

Discussion {#S0004}
==========

KD is thought to be an acute and self-limited vasculitis. Most researches focus on changes that occur during the acute phase,especially changes in the medium-sized coronary artery. In the convalescent period, long-term follow-up is suggested for patients with persistent CALs, but sequels are not frequently studied in patients without CALs during the acute phase. Due to challenges in animal models and a lack of pathological samples, it is difficult to perform a direct and comprehensive evaluation of the vascular system. Indirect and noninvasive surrogate measures that reflect vascular function are thus important in research. As an index of vascular function, r AI can reflect artery stiffness, especially stiffness in the peripheral artery. Until now, very few studies have investigated AI changes in KD, and the results are controversial. Tobayama et al demonstrated that KD subjects had higher AI values than healthy controls,[@CIT0017] but Pinto FF found no difference.[@CIT0018] Both studies had small sample sizes, so larger samples are needed to settle this controversy.

Our study finally enrolled 225 subjects with an age from 6 to 15 years old, 102 patients with KD and 123 healthy controls, and the time interval from disease onset until the study examination ranged from 1 month to nearly 14 years. To the best of our knowledge, this is the only study of AI in a large sample of patients with KD. Our research showed that the rAI was a little but significantly higher in KD patients without CALs during the acute phase than in healthy controls. With regard to acute-phase condition, we found that initial IVIG nonresponse was positively correlated with rAI. This finding is consistent with the phenomenon that IVIG nonresponse was correlated with increased risk of CALs and thus enhanced vascular damage. One confusing finding in our study is that fever duration was negatively correlated with rAI and rAI\@75. It seems contradictory with Mori's opinion[@CIT0019] that persistent high fever for more than 10 days during the acute phase was related to endothelial dysfunction during the convalescent period. But in our study, the fever duration ranged from 3 to 10 days, and all subjects had fever resolution within 10 days. According to Egami[@CIT0020] and Kobayashi's[@CIT0021] research, the one who received initial IVIG before the fifth day of disease onset tended to experience IVIG resistance, whereas no difference was found for the subjects who received the first dose of IVIG between the fifth and tenth day. We thus speculated that this certain fever duration distribution in our study may explain the negative correlation. Multivariable analysis after excuding KD cases who began initial treatment before day 5 after onset verified our speculation, but further studies are needed to confirm this result. The increased value of rAI in patients with KD may be due to peripheral vascular changes in the convalescent period. As the rAI is an index that is strongly related to the peripheral artery and vascular bed, this suggested that not only medium-sized arteries were affected by KD, but also smaller arteries. In adults, central aortic AI had been demonstrated as an independent predictor of mortality in end-stage renal disease patients.[@CIT0022],[@CIT0023] Moreover, its predictive value of CV events in patients undergoing percutaneous coronary intervention and the hypertensive patients has also been verified; in children, although many pathological conditions such asobesity, diabetes,[@CIT0024] systemic hypertension,[@CIT0025] insulin resistance,[@CIT0026] dyslipidemia,[@CIT0027] and chronic kidney disease[@CIT0028] have been linked with increased AI, due to the lack of long-term follow-up studies, the clinical importance of AI in children is still unclear and needed to be clarified.

However, our study has some limitations. We have not detected the serum lipid profile in our subjects, although they did not have a dyslipidemia history. The difference in serum lipid and cholesterol between groups may contribute to rAI change. Second, our study was not longitudinal, and data collection was not taken at every time point. It is possible that periodic data collection is needed to better reflect dynamic changes in vascular function. Third, our study just analyzed the rAI difference in children between 6 and 15 years old; this conclusion cannot be applied to an extended age range. Last, our study only included Japanese patients, and the results may be different in other ethnic groups.

Conclusions {#S0005}
===========

In conclusion, the rAI values were higher in KD patients without acute-phase CALs than in healthy controls. Elevated rAI means the reflection wave from the peripheral vascular is stronger or earlier. This small but significant change may indicate the existence of peripheral artery stiffness during the convalescent period in KD patients without acute CALs. It implied the peripheral vascular system was not in ideal health even when no acute CALs happened.

Abbreviation list {#S0006}
=================

BW, body weight; HT, height; HR, heart rate; BP, blood pressure; BMI, body mass index; BSA, body surface area; KD, Kawasaki disease; IVIG, intravenous immunoglobulin; WBC, white blood cell; CRP, C-reactive protein; CALs, coronary artery lesions; rAI, radial artery augmentation index; rAI\@75, radial augmentation index adjusted to heart rate 75 bpm.
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[^1]: **Notes:** ^†^Pearson Chi-square test was used. \*Mann--Whitney U test was used.

[^2]: **Abbreviations:** KD, Kawasaki disease; rAI, radial artery augmentation index; rAI\@75, radial artery augmentation index adjusted to heart rate in 75 bpm.

[^3]: **Note: \*\*\****p*\<0.001.

[^4]: **Abbreviations:**KD, Kawasaki disease; rAI, radial artery augmentation index.

[^5]: **Notes: \****p*\<0.05, **\*\****p*\<0.01, **\*\*\****p*\<0.001.

[^6]: **Abbreviations:** KD, Kawasaki disease; rAI, radial artery augmentation index; rAI\@75, radial artery augmentation index adjusted to heart rate in 75 bpm.

[^7]: **Notes: \****p*\<0.05, **\*\****p*\<0.01

[^8]: **Abbreviations:** KD, Kawasaki disease; rAI, radial artery augmentation index; rAI\@75, radial artery augmentation index adjusted to heart rate in 75 bpm.

[^9]: **Notes: \****p*\<0.1, **\*\****p*\<0.05.
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